MAPT and Alzheimer disease: Alzheimer’s disease (AD) is a progressive neurodegenerative disorder characterized by cognitive decline, amyloid-β (Aβ) plaque accumulation, tau hyperphosphorylation, Ca2+ homeostasis dysregulation, and neuroinflammation [1,2].